MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-TS-20-0011633
Spansules Pharmatech Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹73.76 Cr
▼ 4% YoY
Net profit · FY 2025
₹1.73 Cr
Net margin 2.3%
EBITDA · FY 2025
₹8.06 Cr
EBITDA margin 10.9%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹5 Cr
Issued & subscribed
Open charges
₹57.24 Cr
Satisfied ₹8 Cr
Company age
26 yrs
Est. 2000
Employees · EPFO
52
Provident fund records
About Spansules Pharmatech Private Limited
Data last updated:
Spansules Pharmatech Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 October 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2000PTC035421. Its GSTIN is 36AAFCS7057K1ZW (Telangana). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹5 Cr. It is led by directors including Venkata Subba Rao Guttikonda (Managing Director) and Rama Devi Guttikonda.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.59 G – 3 Sri Venkateswara Towers Bhagyanagar Colony, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2025, the company reported a revenue of ₹73.76 Cr, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹1.73 Cr (net margin 2.3%) and EBITDA of ₹8.06 Cr (EBITDA margin 10.9%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 5% over five years.
The company has about 52 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Spansules Pharmatech and Spansules. As per MCA filings, the company has open charges of ₹57.24 Cr and satisfied charges of ₹8 Cr on record. Court records list 9 cases involving the company, including 9 filed by the company; 4 cases are pending. The company has 4 deals on record (2 funding rounds, 2 rights issues), with disclosed funding of ₹1.83 Cr; the latest was in August 2023. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Atlas Pharmachem Industries Private Limited with revenue of ₹74.83 Cr.
Spansules Pharmatech Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0011633). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website spansulespharma.com.
Company details
CIN U24230TG2000PTC035421
Registration Number 035421
Incorporation Date 09 October 2000
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-20-0011633
CIN history
Spansules Pharmatech has one previous CIN (Corporate Identification Number): U24230AP2000PTC035421. The current CIN is U24230TG2000PTC035421, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG2000PTC035421 | Current |
| U24230AP2000PTC035421 | Previous |
Key People
Venkata Subba Rao Guttikonda Managing Director Rama Devi Guttikonda Director Haswanth Rao Guttikonda Director Recognitions & Rankings of Spansules Pharmatech
Contact details
Spansules Pharmatech Private Limited's registered office is in Hyderabad, Telangana. Its website is spansulespharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No.59 G – 3 Sri Venkateswara Towers Bhagyanagar Colony, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Spansules Pharmatech Private Limited, buy the company report.
Comprehensive company report
Spansules Pharmatech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Spansules Pharmatech operates two associated brands: Spansules Pharmatech and Spansules. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| A WHO GMP and ISO 9001:2008 certified manufacturer and exporter of pharmaceutical pellets. | spansulespharma.net | |
| Pharmaceutical pellet manufacturing and formulation development in India. | spansulespharma.com |
Business activity
The main business activity of Spansules Pharmatech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Spansules Pharmatech Private Limited, buy the company report.
Financials of Spansules Pharmatech Private Limited
FY 2025 filings availableSpansules Pharmatech Private Limited reported revenue of ₹73.76 Cr (down 4% YoY) for FY 2025.
Revenue · FY 2025
₹73.76 Cr ▼ 4%
Net profit · FY 2025
₹1.73 Cr margin 2.3%
EBITDA · FY 2025
₹8.06 Cr margin 10.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 4%
3 years · compounded
▼ 2%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▼ 3%
3 years · compounded
▲ 21%
5 years · compounded
▲ 15%
Revenue fell 4% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 5%. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.06 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.73 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.9% | ||||
| Net Profit Margin | 2.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Spansules Pharmatech Private Limited, buy the company report.
Board of directors of Spansules Pharmatech Private Limited
Spansules Pharmatech has 4 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rama Devi Guttikonda | Director | 09 Oct 2000 | 26 Years 0 Months | Current |
| Haswanth Rao Guttikonda | Director | 07 Feb 2020 | 6 Years 8 Months | Current |
| Harika Rao Guttikonda | Director | 07 Feb 2020 | 6 Years 8 Months | Current |
| Venkata Subba Rao Guttikonda | Managing Director | 09 Oct 2000 | 26 Years 0 Months | Current |
Peer comparison
Spansules Pharmatech Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Atlas Pharmachem Industries Private Limited | ₹74.83 Cr (FY 2025) | 5.0% | Ahmedabad, Gujarat, India | |||
| Casid Pharmaceuticals Private Limited | ₹74.41 Cr (FY 2025) | 28.0% | Manachanalloor, Tamil Nadu, India | |||
| Unispeed Pharmaceuticals Private Limited | ₹74.03 Cr (FY 2025) | 8.0% | Baddi, Himachal Pradesh, India | |||
| Spansules Pharmatech Private Limitedthis company | ₹73.76 Cr (FY 2025) | ₹1.73 Cr | 2.3% | -4.0% | 52 | Hyderabad, Telangana, India |
| Shiva Biogenetic Laboratories Private Limited | ₹73.64 Cr (FY 2025) | 2.0% | Baddi, Himachal Pradesh, India | |||
| Avn Ayurveda Formulations Private Limited | ₹72.9 Cr (FY 2025) | 6.0% | Madurai, Tamil Nadu, India | |||
| Eskay Herbal Formulations Private Limited | ₹72.88 Cr (FY 2025) | -3.0% | Jalgaon, Maharashtra, India |
To see the full peer comparison of Spansules Pharmatech Private Limited, buy the company report.
Auditor
Spansules Pharmatech Private Limited is audited by RAO&SIVAASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAO&SIVAASSOCIATES | FY 2023 | 208776 |
Shareholding
The shareholding of Spansules Pharmatech Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Spansules Pharmatech Private Limited, buy the company report.
Charges & borrowings
Open charges
₹57.24 Cr
Satisfied charges
₹8 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Sep 2025 | 101198090 | Canara Bank | ₹2 Cr | Open | |
| 10 May 2022 | 100586682 | Hdfc Bank Limited | ₹20 Lakh | Open | |
| 08 Feb 2022 | 100540796 | Hdfc Bank Limited | ₹24.77 Cr | Open | |
| 27 May 2015 | 10575835 | Canara Bank | ₹8 Lakh | Open | |
| 21 Oct 2010 | 10249474 | Canara Bank | ₹3 Lakh | Open |
To see the full charge records of Spansules Pharmatech Private Limited, buy the company report.
Total charge records: 8 View all charges
Deals & funding
Spansules Pharmatech Private Limited has 4 deals on record (2 funding rounds, 2 rights issues), with disclosed funding of ₹1.83 Cr; the latest was in August 2023.
Total deals
4
Funding rounds
2
Rights issues
2
Disclosed funding
₹1.83 Cr
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2023 | Rights issue | ₹1.77 Cr | Investors: 2 individuals |
| Mar 2016 | Rights issue | ₹1.26 Cr | Investors: 4 individuals |
| Apr 2012 | Funding round | ₹96.1 Lakh | Investors: 2 individuals |
| Oct 2009 | Funding round | ₹86.5 Lakh | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Spansules Pharmatech Private Limited has 9 court cases on record: 9 filed by Spansules Pharmatech. 4 cases are pending and 5 are disposed.
Total cases
9
Filed by the company
9
Pending
4
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 0 | 4 |
| High courts | 1 | 0 | 0 |
Cases on record (5 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Medchal Malkajgiri, Telangana | Civil suit | Filed by the company against Delius Pharmaceuticals Pvt Ltd | Pending |
| District court, Medchal Malkajgiri, Telangana | Civil suit | Filed by the company against Vivimed Labs Ltd | Disposed |
| District court, Medchal Malkajgiri, Telangana | Cheque dishonour complaint | Filed by the company against Solatium Pharmaceuticals Rep by Its Managing Partner Kashinath Ghosh | Pending |
| High Court of Andhra Pradesh | Writ petition | Filed by the company against The State of Ap and 1 other | Disposed |
| District court, Sangareddy, Telangana | Civil suit | Filed by the company against an individual | Disposed |
To see the full case history of Spansules Pharmatech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Spansules Pharmatech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Spansules Pharmatech Private Limited has a workforce of 52 employees on its EPFO records as of Sep 25, 2025, across 1 active EPFO establishment.
Employee count
52
Active EPFO establishments
1
GST
Spansules Pharmatech has 4 GST registrations: 2 active and 2 cancelled or inactive.
Total GSTINs
4
Active
2
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCS7057K1ZW | Telangana | Active | 01 Jul 2017 |
| 37AAFCS7057K3ZS | Andhra Pradesh | Active | 29 Mar 2020 |
To see the full GST registrations and return filing status of Spansules Pharmatech Private Limited, buy the company report.
Recent activity
Spansules Pharmatech Private Limited has 4 board changes on record since 2000: 4 appointments. The latest: Harika Rao Guttikonda was appointed as Director on 07 Feb 2020.
AGM
Spansules Pharmatech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Canara Bank amounted to Rs. 2.00 Cr with Charge ID 101198090 was registered on 19 Sep 2025.
Filing
Spansules Pharmatech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Canara Bank of Rs. 30.13 Cr registered on 13 Jun 2002 with Charge ID 90128215 was modified on 21 Jan 2023.
Charges
A charge with Hdfc Bank Limited of Rs. 24.77 Cr registered on 08 Feb 2022 with Charge ID 100540796 was modified on 07 Jun 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.20 Cr with Charge ID 100586682 was registered on 10 May 2022.
Charges
A charge registered on 23 Sep 2021 via Charge ID 100483729 with Others was fully satisfied on 29 Mar 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 24.77 Cr with Charge ID 100540796 was registered on 08 Feb 2022.
Charges
A charge with Others amounted to Rs. 8.00 Cr with Charge ID 100483729 was registered on 23 Sep 2021.
Appointed
Harika Rao Guttikonda was appointed as Director.
Appointed
Haswanth Rao Guttikonda was appointed as Director.
Charges
A charge with Canara Bank amounted to Rs. 0.08 Cr with Charge ID 10575835 was registered on 27 May 2015.
7 earlier events are in the company report.
Frequently asked questions
Spansules Pharmatech is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 October 2000 (26+ years old) and is registered under CIN U24230TG2000PTC035421.
Spansules Pharmatech has 4 current directors:
- Venkata Subba Rao Guttikonda - Managing Director
- Rama Devi Guttikonda - Director
- Haswanth Rao Guttikonda - Director
- Harika Rao Guttikonda - Director
The latest financial statements of Spansules Pharmatech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Spansules Pharmatech is 36AAFCS7057K1ZW, registered in Telangana. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 37AAFCS7057K3ZS (Andhra Pradesh).
The CIN (Corporate Identification Number) of Spansules Pharmatech is U24230TG2000PTC035421. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spansules Pharmatech has 9 court cases on record: 9 filed by the company. 4 are pending. Most are in the district courts.
Spansules Pharmatech was incorporated on 09 October 2000, making it 26+ years old. It is registered with the Registrar of Companies, Hyderabad.
Spansules Pharmatech has 4 deals on record (2 funding rounds, 2 rights issues), with disclosed funding of ₹1.83 Cr; the latest was in August 2023.
The peers of Spansules Pharmatech by revenue are Atlas Pharmachem Industries Private Limited, Casid Pharmaceuticals Private Limited, Unispeed Pharmaceuticals Private Limited, Shiva Biogenetic Laboratories Private Limited, Avn Ayurveda Formulations Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Harika Rao Guttikonda was appointed as Director on 07 Feb 2020. Haswanth Rao Guttikonda was appointed as Director on 07 Feb 2020. Rama Devi Guttikonda was appointed as Director on 09 Oct 2000. Spansules Pharmatech has 4 board changes on record in total.
Yes, Spansules Pharmatech is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-20-0011633).